1800 202 8726
Breast lump evaluation

Triple Assessment for a Breast Lump: — What Concordance Means

Triple assessment is the standard that NICE and EUSOMA set for evaluating any new breast lump. It combines three types of information because each one has blind spots the others can cover.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

  • Three tests, one combined conclusion — Clinical examination, imaging and tissue sampling are reviewed together — not as three separate opinions.
  • Concordance is what makes it reliable — When all three agree, the combined result carries far more weight than any one test alone.
  • Disagreement triggers action — When results conflict, the most concerning one drives the next step — not the most reassuring.
  • Designed to catch what single tests miss — A lump can feel benign, look normal on imaging, and still produce abnormal cells on biopsy.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Triple assessment combines clinical examination, breast imaging and tissue sampling into one coordinated evaluation. When all three results agree — called concordance — the combined finding is far more reliable than any one test alone. When they disagree, the most concerning result determines what happens next, regardless of what the others show.

What is triple assessment for a breast lump?

Triple assessment evaluates a breast lump using three components reviewed together: a specialist physical examination, breast imaging (ultrasound, mammography, or both), and a tissue test — either fine needle aspiration cytology (FNAC) or a core needle biopsy.

Each test has blind spots the others can cover. A lump can feel benign on examination but contain abnormal cells under the microscope. A scan can appear entirely normal in tissue that contains an early cancer.

NICE and EUSOMA both recommend triple assessment as standard because the combination catches a proportion of cancers that any single test would miss.

What does concordance mean in triple assessment?

Concordance means all three components reach the same conclusion — all benign, all uncertain, or all pointing to cancer. When the results agree, your team can state a conclusion with considerably more confidence.

Discordance means the results disagree. A lump that feels benign but produces suspicious cells on biopsy, or a normal-looking scan alongside an abnormal tissue result — these cannot be resolved by taking the most reassuring of the three.

Your team should review all three together and state a single combined conclusion. Ask specifically whether your results are concordant before leaving the clinic.

What to confirm before you leave the assessment clinic

  • Ask whether all three components have been reviewed together and a combined conclusion has been reached.
  • Ask directly: are the results concordant (all agree) or discordant (they disagree)?
  • Ask what category grade each result received — benign, indeterminate, suspicious, or malignant.
  • If any result is Category 3 or above, ask what the next step is and when it will happen.
  • Ask when your follow-up is and what change in the lump should prompt you to call before then.
  • If the consultation was a lot to absorb, ask for a written summary of the conclusion and the plan.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What do the grading terms mean?

Concordant
All three results point to the same conclusion. A concordant benign triple assessment is the most reassuring outcome the assessment can produce.
Discordant
The results disagree with one another. Any discordance requires further investigation before a conclusion can be drawn.
Category 1 or 2 (Normal or benign)
No concerning features were found by that component. Both are individually reassuring, but the combined concordant picture is what matters.
Category 3 (Indeterminate)
The result is genuinely uncertain — not a mild form of benign. Category 3 always requires further investigation, usually a repeat or larger biopsy.
Category 4 or 5 (Suspicious or malignant)
Concerning or clearly malignant features were found. These grades require action regardless of what the other two components show.
FNAC
Fine needle aspiration cytology — a quick tissue test using a thin needle, usually done in the same clinic visit.
Core needle biopsy
A slightly larger tissue sample than FNAC, giving the pathologist more material and usually a more definitive result.

What happens when the three results do not agree?

When results are discordant, the most concerning finding drives the next decision — not the most reassuring. A suspicious biopsy result is acted upon even when the examination felt benign and the scan looked entirely normal.

Discordance does not mean something has gone wrong. It means more information is needed before the picture is complete — usually a repeat biopsy or a different type of sampling.

This is where triple assessment earns its role as a safety net: it is built to flag disagreements rather than allow a reassuring result to mask a concerning one.

Questions families often ask after triple assessment

Does a concordant benign result mean I am clear?

A concordant benign result is the most reassuring outcome triple assessment can produce. NICE guidance recognises it as a basis for discharge or planned surveillance, depending on your clinical picture. That said, a breast lump that changes before your next appointment — grows, hardens, or accompanies new symptoms — should prompt a return visit even after a fully concordant benign result. Reassurance has conditions, and change is the main one to watch for.

Why did I need a biopsy if the scan looked normal?

Breast imaging is one component of a three-part protocol, not a standalone answer. A proportion of breast cancers are not visible on ultrasound or mammography, particularly in dense breast tissue. Tissue sampling is part of the standard protocol precisely because of this blind spot. A normal scan together with a biopsy showing no abnormal cells — both concordant — gives considerably more reassurance than either result alone.

What does a Category 3 (indeterminate) result mean?

Category 3 is not a mild form of benign — it means the pathologist cannot confirm from that sample whether the tissue is clearly benign or clearly malignant. Most guidelines, including NICE, recommend resolving Category 3 with a repeat biopsy, a larger sample, or in some cases surgical excision. Ask your team for a specific next step and a timeline before leaving the clinic.

Can triple assessment still miss a cancer?

No combination of tests has a zero miss rate, and triple assessment is no exception. The combination is designed to reduce that risk substantially compared with any single component — which is precisely why all three are done. If your result is concordant benign but the lump changes before your next appointment, contact your team rather than waiting for the scheduled visit.

What is the difference between FNAC and a core biopsy?

FNAC uses a fine needle to draw cells from the lump, is usually done during the same clinic visit, and produces results quickly. A core biopsy takes a small cylinder of tissue, gives the pathologist more material to assess, and usually produces a more definitive category grade. Your team may recommend one, the other, or both, depending on what the examination and imaging showed.

I have a benign result but I am still not reassured. What should I do?

Name this directly to your treating oncologist or breast surgeon. They can explain which specific features were assessed in your case, whether any aspect of your clinical picture warrants closer surveillance, and whether a second opinion would help. Persistent concern is a reason to continue the conversation with your team — not something to manage alone, and not irrational after having a lump investigated.

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

HUB — How Accurate Is a Biopsy? Repeats, Errors and Second Opinions

HUB — IHC and Molecular Markers on a Biopsy

HUB — Labs, Slides and Second Opinions on a Biopsy

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

What is triple assessment for a breast lump?

Triple assessment evaluates a breast lump using three components together: a specialist physical examination, breast imaging and a tissue test. The three are reviewed as a combined conclusion, not separately. NICE and EUSOMA recommend this combination as standard because each test has blind spots the others can cover, and together they catch a proportion of cancers that any single test would miss.

What does concordant mean on a breast lump report?

Concordant means all three components of the triple assessment agree — all benign, all uncertain, or all malignant. A concordant benign result is the most reassuring outcome the assessment can produce. Discordant means they disagree, and that always requires further investigation. If your report does not specify concordant or discordant, ask your team directly before assuming the best result tells the whole story.

What does a Category 3 biopsy result mean?

Category 3 (indeterminate) means the result is genuinely uncertain — not a mild form of benign. The pathologist cannot confirm from that sample whether the tissue is benign or malignant. Most guidelines, including NICE, recommend resolving it with a repeat or larger biopsy, or in some cases surgical excision. Ask your team for a specific plan and a timeline, not just reassurance.

What happens if one test says benign but another says suspicious?

The most concerning result determines what happens next — not the most reassuring one. A suspicious biopsy or imaging finding is acted upon even when the physical examination felt entirely benign. This is a deliberate feature of how triple assessment works: discordance flags the need for more information, and a reassuring result in one component does not override a concerning one in another.

How long does triple assessment take?

Some breast centres complete all three components in a single visit, with results available the same day. In other settings, biopsy results are returned after laboratory processing, which may take several days. Ask at your appointment whether all results will be available on the day and, if not, when to expect them and how they will be communicated to you.

Is triple assessment available at CION?

Yes. Breast evaluation at CION includes clinical assessment, coordination of breast imaging with partner imaging centres, and tissue sampling as day care. After your results are reviewed together, your team will explain the combined conclusion and the next step. Ask specifically whether your result is concordant before leaving the appointment.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation